Skip to main content


Breast Cancer Research and Treatment

Breast Cancer Research and Treatment 2/2019

Ausgabe 2/2019

Inhaltsverzeichnis ( 26 Artikel )

30.11.2018 | Review | Ausgabe 2/2019 Open Access

Second International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions)

Christoph J. Rageth, Elizabeth A. M. O’Flynn, Katja Pinker, Rahel A. Kubik-Huch, Alexander Mundinger, Thomas Decker, Christoph Tausch, Florian Dammann, Pascal A. Baltzer, Eva Maria Fallenberg, Maria P. Foschini, Sophie Dellas, Michael Knauer, Caroline Malhaire, Martin Sonnenschein, Andreas Boos, Elisabeth Morris, Zsuzsanna Varga

06.12.2018 | Review | Ausgabe 2/2019

Identifying adherence barriers to oral endocrine therapy among breast cancer survivors

Rutugandha Paranjpe, Grace John, Meghana Trivedi, Susan Abughosh

08.12.2018 | Review | Ausgabe 2/2019

Leveraging the variable natural history of ductal carcinoma in situ (DCIS) to select optimal therapy

Kristin E. Rojas, Thais A. Fortes, Patrick I. Borgen

12.12.2018 | Review | Ausgabe 2/2019

Clinical findings and outcomes of MRI staging of breast cancer in a diverse population

Akshara Raghavendra, Julie Wecsler, Lingyun Ji, Pulin Sheth, Charite Ricker, Terry Church, Richard Sposto, Julie Lang, Stephen Sener, Linda Larsen, Debu Tripathy

02.01.2019 | Review | Ausgabe 2/2019

Peer support interventions for breast cancer patients: a systematic review

Jieman Hu, Xue Wang, Shaoning Guo, Fangfang Chen, Yuan-yu Wu, Fu-jian Ji, Xuedong Fang

02.01.2019 | Review | Ausgabe 2/2019

An updated systematic review of the cost-effectiveness of therapies for metastatic breast cancer

Anagha Gogate, Jason S. Rotter, Justin G. Trogdon, Ke Meng, Christopher D. Baggett, Katherine E. Reeder-Hayes, Stephanie B. Wheeler

02.01.2019 | Review | Ausgabe 2/2019

The clinical utility of baseline cardiac assessments prior to adjuvant anthracycline chemotherapy in breast cancer: a systematic review and meta-analysis

Pierre O’Brien, Kara Matheson, Alwin Jeyakumar, Kim Anderson, Tallal Younis

03.12.2018 | Preclinical study | Ausgabe 2/2019

Genomic profile of breast sarcomas: a comparison with malignant phyllodes tumours

Sue Zann Lim, Cedric Chuan Young Ng, Vikneswari Rajasegaran, Peiyong Guan, Sathiyamoorthy Selvarajan, Aye Aye Thike, Nur Diyana Binte Md Nasir, Valerie Cui Yun Koh, Benita Kiat Tee Tan, Kong Wee Ong, Bin Tean Teh, Puay Hoon Tan

08.12.2018 | Preclinical study | Ausgabe 2/2019

KRT19 and CEACAM5 mRNA-marked circulated tumor cells indicate unfavorable prognosis of breast cancer patients

Xi-Mei Wang, Zhen Zhang, Li-Hui Pan, Xu-Chen Cao, Chunhua Xiao

15.12.2018 | Preclinical study | Ausgabe 2/2019

Overexpression of the cancer stem cell marker CD133 confers a poor prognosis in invasive breast cancer

Chitra Joseph, Maariya Arshad, Sasagu Kurozomi, Maryam Althobiti, Islam M. Miligy, Sara Al-izzi, Michael S. Toss, Fang Qin Goh, Simon J. Johnston, Stewart G. Martin, Ian O. Ellis, Nigel P. Mongan, Andrew R. Green, Emad A. Rakha

17.12.2018 | Preclinical study | Ausgabe 2/2019

The estrogen receptor-alpha S118P variant does not affect breast cancer incidence or response to endocrine therapies

Berry Button, Sarah Croessmann, David Chu, D. Marc Rosen, Daniel J. Zabransky, W. Brian Dalton, Karen Cravero, Kelly Kyker-Snowman, Ian Waters, Swathi Karthikeyan, Eric S. Christenson, Josh Donaldson, Tasha Hunter, Lauren Dennison, Cody Ramin, Betty May, Richard Roden, Dana Petry, Deborah K. Armstrong, Kala Visvanathan, Ben Ho Park

29.12.2018 | Preclinical study | Ausgabe 2/2019 Open Access

Adipose stem cell crosstalk with chemo-residual breast cancer cells: implications for tumor recurrence

Matthew A. Lyes, Sturgis Payne, Paul Ferrell, Salvatore V. Pizzo, Scott T. Hollenbeck, Robin E. Bachelder

04.12.2018 | Clinical trial | Ausgabe 2/2019

Combination of different types of elastography in downgrading ultrasound Breast Imaging-Reporting and Data System category 4a breast lesions

Xueyi Zheng, Yini Huang, Yun Wang, Yubo Liu, Fei Li, Jing Han, Jianwei Wang, Longhui Cao, Jianhua Zhou

07.12.2018 | Clinical trial | Ausgabe 2/2019

Metformin plus chemotherapy versus chemotherapy alone in the first-line treatment of HER2-negative metastatic breast cancer. The MYME randomized, phase 2 clinical trial

O. Nanni, D. Amadori, A. De Censi, A. Rocca, A. Freschi, A. Bologna, L. Gianni, F. Rosetti, L. Amaducci, L. Cavanna, F. Foca, S. Sarti, P. Serra, L. Valmorri, P. Bruzzi, D. Corradengo, A. Gennari, MYME investigators

02.01.2019 | Clinical trial | Ausgabe 2/2019

Neutrophil-to-lymphocyte ratio as a predictor of survival in patients with triple-negative breast cancer

Dilan A. Patel, Jing Xi, Jingqin Luo, Bilal Hassan, Shana Thomas, Cynthia X. Ma, Jian L. Campian

02.01.2019 | Clinical trial | Ausgabe 2/2019

Association between breast cancer risk factors and molecular type in postmenopausal patients with hormone receptor-positive early breast cancer

Marius Wunderle, Jutta Pretscher, Sara Y. Brucker, Bernhard Volz, Arndt Hartmann, Cornelia Fiessler, Alexander Hein, Lothar Häberle, Sebastian M. Jud, Michael P. Lux, Wolfgang Janni, Christian R. Loehberg, Andreas D. Hartkopf, Christina B. Walter, Gerold Baake, Alexander Fridman, Wolfram Malter, Rachel Wuerstlein, Nadia Harbeck, Oliver Hoffmann, Sherko Kümmel, Bernhard Martin, Christoph Thomssen, Heiko Graf, Christopher Wolf, Christian M. Bayer, Carolin C. Hack, Katrin Almstedt, Paul Gass, Felix Heindl, Tobias F. Brodkorb, Naiba Nabieva, Christoph Lindner, Hans-Christian Kolberg, Petra Krabisch, Michael Weigel, Dieter Steinfeld-Birg, Andreas Kohls, Cosima Brucker, Volker Schulz, Gunnar Fischer, Volker Pelzer, Diethelm Wallwiener, Brigitte Rack, Tanja Fehm, Achim Rody, Nicolai Maass, Matthias W. Beckmann, Peter A. Fasching, Claudia Rauh

03.12.2018 | Epidemiology | Ausgabe 2/2019

Yield of surveillance magnetic resonance imaging after bilateral mastectomy and reconstruction: a retrospective cohort study

Orit Golan, Yoav Amitai, Yoav Barnea, Tehillah S. Menes

04.12.2018 | Epidemiology | Ausgabe 2/2019

A clinically structured and partnered approach to genetic testing in Trinidadian women with breast cancer and their families

Talia Donenberg, Sophia George, Jameel Ali, Gabriela Bravo, Karen Hernandez, Navin Sookar, Kimlin Tam Ashing, Steven A. Narod, Mohammad R. Akbari, Judith Hurley

11.12.2018 | Epidemiology | Ausgabe 2/2019 Open Access

Significant inter- and intra-laboratory variation in grading of ductal carcinoma in situ of the breast: a nationwide study of 4901 patients in the Netherlands

Carmen van Dooijeweert, Paul J. van Diest, Stefan M. Willems, Chantal C. H. J. Kuijpers, Lucy I. H. Overbeek, Ivette A. G. Deckers

14.12.2018 | Epidemiology | Ausgabe 2/2019 Open Access

Diagnostic pathways and management in women with pregnancy-associated breast cancer (PABC): no evidence of treatment delays following a first healthcare contact

Anna L. V. Johansson, Caroline E. Weibull, Irma Fredriksson, Mats Lambe

17.12.2018 | Epidemiology | Ausgabe 2/2019 Open Access

Examination of a paradox: recurrent metastatic breast cancer incidence decline without improved distant disease survival: 1990–2011

Judith Malmgren, Marc Hurlbert, Mary Atwood, Henry G. Kaplan

17.12.2018 | Epidemiology | Ausgabe 2/2019

Prevalence of breast cancer-related risk factors in underweight premenopausal women: the Korea National Health and Nutrition Examination Survey IV–VI

Joo Heung Kim, Kwang Hyun Yoon, Ho Hur, Seho Park, Jee Ye Kim, Hyung Seok Park, Seung II Kim, Young Up Cho, Byeong-Woo Park

18.12.2018 | Epidemiology | Ausgabe 2/2019

The mammography screening detection of ductal carcinoma in situ and invasive breast cancer according to women’s characteristics: is it the same?

Isabelle Théberge, Nathalie Vandal, Marie-Hélène Guertin, Linda Perron

02.01.2019 | Epidemiology | Ausgabe 2/2019

Patient-centered simulations to assess the usefulness of the 70-gene signature for adjuvant chemotherapy administration in early-stage breast cancer

Emmanuel Caruana, Yohann Foucher, Philippe Tessier, Jean-Sébastien Frenel, Jean-Marc Classe, Etienne Dantan

14.12.2018 | Brief Report | Ausgabe 2/2019

Alternative transcript imbalance underlying breast cancer susceptibility in a family carrying PALB2 c.3201+5G>T

Laura Duran-Lozano, Gemma Montalban, Sandra Bonache, Alejandro Moles-Fernández, Anna Tenés, Marta Castroviejo-Bermejo, Estela Carrasco, Adrià López-Fernández, Sara Torres-Esquius, Neus Gadea, Neda Stjepanovic, Judith Balmaña, Sara Gutiérrez-Enríquez, Orland Diez

13.12.2018 | Letter to the Editor | Ausgabe 2/2019

Ectopic breast tissue and cancer

Alessandro Sindoni, Maria Gioffré-Florio, Fausto Famá

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.